SUBLIME: SUCCESS BEYOND 1ST LINE ANTIRETROVIRAL MEDICATIONS



Trademark Coverage

No Class Specified

Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use

Owner
Timeline
  • May 20
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • May 20
    2013
    Abandonment No Use Statement Filed
  • Apr 03
    2013
    TEAS Change Of Correspondence Received
  • Oct 16
    2012
    NOA E Mailed SOU Required From Applicant
  • Aug 21
    2012
    Official Gazette Publication Confirmation E Mailed
  • Aug 21
    2012
    Published For Opposition
  • Aug 01
    2012
    Notification Of Notice Of Publication E Mailed
  • Jun 30
    2012
    Approved For PUB Principal Register
  • Jun 29
    2012
    Assigned To Examiner
  • May 10
    2012
    Notice Of Pseudo Mark Mailed
  • May 09
    2012
    New Application Office Supplied Data Entered In TRAM
  • May 07
    2012
    New Application Entered In TRAM